MedPath

Role of pregabalin given pre-operatively in patients undergoing total abdominal hysterectomy under spinal anaesthesia

Not Applicable
Conditions
Health Condition 1: O9A1- Malignant neoplasm complicating pregnancy, childbirth and the puerperium
Registration Number
CTRI/2021/01/030736
Lead Sponsor
Dr Sania Almeida
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

ASA grade 1 and 2

Patients undergoing Total abdominal hysterectomy

Exclusion Criteria

Allergy to pregabalin

patient on antiplatlet and anticoagulants

consumption of Nsaids in last 48hours

Coagulation abnormalities

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reduction in requirement of post operative analgesiaTimepoint: Reduction in requirement of post operative analgesia <br/ ><br>VAS score to be assessed at 2,4,8,12and 24hrs post operatively
Secondary Outcome Measures
NameTimeMethod
nilTimepoint: nil
© Copyright 2025. All Rights Reserved by MedPath